Navigation Links
IOF calls for action following release of Eastern European & Central Asian Regional Audit
Date:2/24/2011

A newly published audit report by the International Osteoporosis Foundation (IOF) consolidates information on the status and burden of osteoporosis in 21 countries of Eastern Europe and Central Asia, including the Russian Federation. The landmark report 'Eastern European & Central Asian Regional Audit Epidemiology, Costs & Burden of Osteoporosis in 2010' shows alarming projections and reveals the poor status of post-fracture care and osteoporosis management in the region.

IOF President John Kanis called for immediate action, asking all stakeholders in the region to join forces to improve accessibility to osteoporosis diagnosis and treatment, and, most urgently, to improve standards of fracture care. "Without proper post-fracture care, a person who suffers a hip fracture is at risk of early death or condemned to a life of severe disability," he stated.

The key findings of the Audit Report reveal the magnitude of the problem in the region, including:

  • Significant increase in numbers of elderly and hence in fragility fractures expected for most countries in the coming decades
  • No set standards of care and lack of modern surgical treatment of patients after hip fracture in many countries, resulting in widespread disability and high death rates
  • Lack of epidemiological data on fractures and scientific research in the field of osteoporosis in many countries
  • Lack of official government-approved national guidelines on osteoporosis and no formal fragility fracture registries in many countries
  • Vitamin D status and average daily calcium intake far below the WHO recommendations in most countries
  • In countries without reimbursement of drug therapy, treatment remains out of reach for a majority of the population

Preliminary findings from the report were first presented at the IOF Summit of Eastern Europe and Central Asian Osteoporosis Patient Societies in September 2010. National patient and medical societi
'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
International Osteoporosis Foundation
Source:Eurekalert

Page: 1 2

Related biology news :

1. When nature calls
2. Recipe for family mealtimes calls for 3 ingredients in the right amounts
3. President Obama calls for increased investment in science, including biomedical research
4. Bioethics Commission calls for enhanced federal oversight in new field of synthetic biology
5. New study calls for greater awareness of food supply for children with diabetes
6. MU scientist develops salmonella test that makes food safer, reduce recalls
7. Diabetic adults conditions improved after phone calls with fellow patients
8. Wildlife Conservation Society finds wild cat mimicking monkey calls
9. ISWA calls attention to important contribution of waste sector to reduce substantial CO2 emissions
10. Recalls, food worries spark booming business in food safety
11. Research supports calls to study health benefits of nitrate, nitrite
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014 The Nano-Bio Manufacturing Consortium (NBMC), an ... Laboratory (AFRL), has chosen a project proposed by the ... of Arizona College of Medicine – Tucson ... goal is to assess different sweat collection methods and ... sweat under a variety of human-body conditions, the results ...
(Date:10/18/2014)... Among a group of 2,000 patients referred for ... a potential molecular diagnosis for 25 percent, including ... and new mutations contributing to disease, according to ... study is being released to coincide with the ... Whole-exome sequencing analyzes the exons or coding regions ...
(Date:10/17/2014)... To date, antidotes ... doctors are often limited to supportive therapy such as induced ... of drugs involved. So what can be done if a ... professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences at ... "The task was to develop an agent that could eliminate ...
Breaking Biology News(10 mins):Nano-Bio Manufacturing Consortium Selects Project Proposed by Arizona Center for Integrative Medicine to Optimize Human Performance Monitoring Techniques 2Nano-Bio Manufacturing Consortium Selects Project Proposed by Arizona Center for Integrative Medicine to Optimize Human Performance Monitoring Techniques 3Whole-exome sequencing shows potential as diagnostic tool 2Emergency aid for overdoses 2Emergency aid for overdoses 3
... Standards and Technology (NIST) and the German national ... sensor to successfully track a human heartbeat, confirming ... in Applied Physics Letters, * the study ... resembling a clinical setting with the NIST mini-sensors, ...
... Earth,s radiation balance by interacting with solar radiation ... organic compounds are key players in new particle ... role as the newly formed particles cool our ... aerosol (SOA) particles formed from volatile compounds emitted ...
... CAOCT. 13, 2010 -- Alzheimer,s disease (AD) is an ... in its cause and progression. For example, the lipid-transport ... factor for AD, and apoE4 carriers account for 65󈞼% ... to the disease is unclear. Scientists at ...
Cached Biology News:NIST mini-sensor traces faint magnetic signature of human heartbeat 2New research results change the understanding of atmospheric aerosol properties and climate effects 2Gladstone scientists uncover mechanism for the major genetic risk factor of Alzheimer's disease 2
(Date:10/25/2014)... California (PRWEB) October 23, 2014 ... a specialty pharmaceutical company devoted to bringing new ... partnerships in 2015. , ViaDerma has developed an ... allows for rapid mass transfer of pharmaceutical active ... body to provide immediate localized therapy. The transdermal ...
(Date:10/25/2014)... 24, 2014 The Workgroup ... leading nonprofit authority on the use of health ... announces its appointment of four new co-chairs to ... leaders include:, ,     Peter Dumont, Senior ... Pupo, Specialist Leader, Deloitte Consulting LLP , ...
(Date:10/25/2014)... A new way to produce engineered skin not ... grafting technologies, it also speeds up the healing process, ... the October issue of STEM CELLS Translational Medicine, could ... result from severe burns and chronic wounds. , A ... These wounds heal by contraction, with epithelization (the process ...
(Date:10/25/2014)... ROCKVILLE, Md. , Oct. 24, 2014  RegeneRx Biopharmaceuticals, ... on data presented at the Fourth International Symposium on ... , Italy.  "When thymosin beta ... was injected into the peritoneal cavity in a rodent ... vessels and throughout the brain parenchyma (the functional tissue ...
Breaking Biology Technology:ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3WEDI Appoints Four New Security and Privacy Workgroup Co-chairs 2New engineering method shows promise for faster healing, more cosmetically appealing skin grafts 2New engineering method shows promise for faster healing, more cosmetically appealing skin grafts 3Researchers Report Thymosin Beta 4 Crosses Blood-Brain Barrier In Animal Stroke Model 2
... 13 , - Regulated Information, ThromboGenics ... innovative treatments for vascular disease, eye disease and,cancer, ... three month period ended,31 March 2008., Prof. ... on,today,s announcement, said: "ThromboGenics, clinical development programs,are continuing ...
... Nile Therapeutics, Inc.,(Nasdaq: NLTX ), today announced that ... the Rodman & Renshaw 5th Annual Global Healthcare,Conference at ... Meridian Beach,Plaza Hotel in Monte Carlo, Monaco. Mr. Strumph ... of Nile,s current clinical development,programs., The presentation will ...
... Foam Technology with Improved Usability & ... ... Despite the high incidence,of women,s health conditions that require intra-vaginal drug ... survey,found that an alarming majority of women find their current treatment,options ...
Cached Biology Technology:ThromboGenics N.V. - Business Update 2ThromboGenics N.V. - Business Update 3ThromboGenics N.V. - Business Update 4ThromboGenics N.V. - Business Update 5ThromboGenics N.V. - Business Update 6ThromboGenics N.V. - Business Update 7Nile Therapeutics to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference 272% of Women Are Dissatisfied With Their Current Treatment of Vaginal Infection, Survey Finds 2
Rabbit polyclonal to GPCR G2A ( Abpromise for all tested applications). entrezGeneID: 29933 SwissProtID: Q9UNW8...
... has been developed for use with ... of nonspecific background staining due to ... blocking peroxidase with hydrogen peroxide. ... combination with additional novel components to ...
Rabbit polyclonal to Wilms Tumor Protein ( Abpromise for all tested applications). entrezGeneID: 7490 SwissProtID: P19544...
Ku80 Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Biology Products: